Skip to main content

Table 1 Baseline characteristics of the patients

From: Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study

Characteristics AC group(n = 67)
No. (%), Mean ± SD, Median (range)
AT group(n = 54)
No. (%), Mean ± SD, Median (range)
p value
Age 61.4 ± 8.5 58.2 ± 9.3 0.055
BMI, kg/m2 25.5 (23.5, 27.5) 25.7 (24.1, 28.0) 0.257
Sex, male 50 (74.6%) 44 (81.5%) 0.368
Prior PCI 10 (14.9%) 19 (16.7%) 0.794
Atrial fibrillation 2 (3.0%) 2 (3.7%)
Hypertension 45 (67.2%) 34 (64.8%) 0.786
Dyslipidemia 56 (83.6%) 50 (92.6%) 0.135
Diabetes mellitus 30 (44.8%) 21 (38.9%) 0.514
Cerebrovascular event 11 (16.4%) 11 (20.4%) 0.575
Chronic kidney failure 2 (3.0%) 1 (1.9%)
Smoking 39 (58.2%) 40 (74.1%) 0.068
Prior cardiac surgery 1 (1.5%) 1 (1.9%)
Prior myocardial infarction 32 (47.8%) 16 (29.6%) 0.043a
Triple-vessel disease 49 (73.1%) 32 (59.3%) 0.107
NYHA class III or IV 29 (43.3%) 31 (57.4%) 0.122
Preoperative EF, % 62.0 (57.0–66.0) 60.0 (56.0–65.0) 0.449
  1. BMI body mass index, EF ejection fraction, No. number, NYHA New York Heart Association, PCI percutaneous coronary intervention, SD standard deviation
  2. a Statistically significant